Nitrome Biosciences
Latest round
- Series A
Last raised
- Nov 2021
Total raised
- $24M
Investors
- 6
About Nitrome Biosciences
Nitrome Biosciences, Inc.Nitrome Biosciences, Inc. specializes in creating antibody candidates aimed at treating neurodegenerative diseases.Nitrome Biosciences, Inc. focuses on the development of antibody candidates specifically for neurodegenerative diseases such as Parkinson’s Disease. Their primary offerings stem from the NITROME Platform, a proprietary technology designed to identify and characterize nitrases, which are novel enzymes implicated in various diseases. This platform aids in pinpointing new nitrases and their nitro-substrates, revealing their biological functions and therapeutic possibilities.The company generates revenue through strategic partnerships and collaborations with biotech firms and research organizations. Nitrome Biosciences, Inc. may engage in B2B transactions by licensing its NITROME Platform technology for drug development, alongside potential income from milestone payments tied to clinical development progress.Nitrome Biosciences, Inc. Fox Foundation to expedite research on nitrated alpha-synuclein, a potential biomarker for predicting and diagnosing Parkinson’s Disease. This initiative aims to enhance their product development pipeline and could lead to new therapeutic approaches. Furthermore, the company is exploring opportunities to expand its market presence in North America, Europe, and Asia, targeting new partnerships within these regions to leverage their NITROME Platform technology and address broader medical needs associated with neurodegenerative diseases.
Who invested in Nitrome Biosciences
6 investors across 2 rounds
See all investors in Nitrome Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nitrome Biosciences
Who invested in Nitrome Biosciences?
Nitrome Biosciences has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nitrome Biosciences raised?
Nitrome Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nitrome Biosciences last raise money?
Nitrome Biosciences's most recent round on record is a Series A, in Nov 2021.
What does Nitrome Biosciences do?
Nitrome Biosciences is a pharmaceuticals company.
Where is Nitrome Biosciences headquartered?
Nitrome Biosciences is headquartered in Brisbane, US.
Which VCs invest in companies like Nitrome Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Nitrome Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Nitrome Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.